At week 48 , a statistically significantly greater percentage of the terbinafine group than itraconazole group showed negative mycology ( 73 % [ 119 of 163 ] vs 45.8 % [ 77 of 168 ] ; p < 0.0001 ) ( difference = 27.2 % ; 95 % CI = [ 17.0 % , 37.3 % ] ) .
